Stock APGE APOGEE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Apogee Therapeutics, Inc.

Equities

APGE

US03770N1019

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-18 pm EDT 		5-day change 1st Jan Change
36.37 USD -6.72% Intraday chart for Apogee Therapeutics, Inc. -15.83% +30.17%
May. 28 Apogee Therapeutics, Inc. Appoints Lisa Bollinger to Its Board of Directors CI
May. 15 Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases CI
05092e169a.KfnIoKwj8vMd7_A4_Q16p585bOemzJ4mIRt0kYDj92o.H8my09hSrcNetb9cnFoq791uVL-VjshuSmgl1tSAgjVZuP_MzxGdgC6kyA~ec2f770e70d6d8032d987bd74c71cc0d
  1. Stock Market
  2. Equities
  3. APGE Stock
  4. Charts Apogee Therapeutics, Inc.
  5. News Chart